News

The FDA is targeting orange juice. Here’s why, and what the science says.

Orange juice, known for its tangy, sweet taste, could be made with slightly less sugary oranges under a regulation proposed ...

Vertex falls after FDA doubts broad use of chronic pain drug

Vertex Pharmaceuticals Inc. fell after an experimental pain drug failed to provide post-surgery benefits and US regulators ...

The FDA Boss on the Agency’s MAHA Makeover

Dr. Marty Makary has criticized the Food and Drug Administration for being "captured" by Big Food and Big Pharma. Now, the ...

US FDA Approves Teva's Ajovy for Migraine Prevention in Children

(Reuters) -The U.S. Food and Drug Administration on Tuesday approved Ajovy, an injection made by Israeli drugmaker Teva ...

FDA Issues Highest Risk Warning For Nuts

Navarro Pecan Holdings, LLC issued a voluntary recall of 32,670 pounds of pecan products on July 10 due to concerns about ...

FDA raises recall of 64,800 lbs. of butter to second-highest warning level

Missouri-based food company Bunge North America has recalled 64,800 pounds - the equivalent of 1,800 cases - of its NH ...

UCSF professor resigns from Trump’s FDA after right-wing conspiracy theorist calls him ‘leftist saboteur’

Vinay Prasad, a professor who until earlier this year headed a cancer-drugs and health-policy lab at UC San Francisco, ...

FDA Requiring Stronger Safety Labels for Opioid Medications

By Stephanie Brown HealthDay ReporterMONDAY, Aug. 4, 2025 (HealthDay News) -- The U.S. Food and Drug Administration announced ...
STAT20h

After ‘conflicting’ signals from FDA, rare disease drugmaker contemplates closure

Stealth BioTherapeutics, which has been developing a rare disease drug, said it is making contingency plans to close the ...

FDA Issues Nationwide Class II Recall on 32 Tons of Butter

The U.S. Food and Drug Administration (FDA) has elevated a nationwide recall covering 64,800 pounds (that’s 1,800 cases) of ...
Fierce Pharma14h

Vertex narrows near-term development plan for Journavx after FDA naysays broad label in neuropathic pain

After the FDA's landmark approval of the opioid-free acute pain reliever Journavx in January, Vertex Pharmaceuticals has hit ...

FDA Chief Says He Wants Gene Therapy Head Prasad to Return

US Food and Drug Administration Commissioner Marty Makary said he’s trying to persuade Vinay Prasad, the agency’s former head ...